Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of Interval Compressed Regimen Using Four-drugs for Osteosarcoma

NCT03390946 is registered in ClinicalTrials.gov with Byung-Kiu Park as lead sponsor.

NCT NCT03390946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03390946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of Interval Compressed Regimen Using Four-drugs for Osteosarcoma
Lead sponsor
Byung-Kiu Park
Phase
Phase 2
Overall status
Unknown status
Start date
February 1, 2018
Completion date
December 31, 2020
Enrollment
23 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarker, feasibility, osteosarcoma, treatment response